Delivery Order SPE2DB22D3016-SPE2DB25FBHD1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of TALTZ 80 mg/ml auto-injector (2-pack) with a ceiling value of $9,029.13 under a firm fixed-price contract type. This award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999.9 million through December 2026. The contract was competitively awarded with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of TALTZ 80 mg/ml auto-injector medication. This non-set-aside, competitively awarded contract carries a ceiling value of $6,641.24 under a firm fixed price arrangement, with an ultimate completion date of August 19, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which...
- The Defense Logistics Agency awarded a $22,497.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for TALTZ 80 mg/ml autoinjector supply. This is a firm fixed price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,228.37 on August 11, 2025, for the supply of TALTZ 80 MG/ML AutoInjector (2-pack). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 12, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract utilizes no set-aside provisions and represents a routine pharmaceutical procurement through established federal...
- The Defense Logistics Agency awarded a $54,688.78 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of TALTZ 80 mg/ml auto-injector (2-pack) pharmaceutical products. This is a non-set-aside competitive award with a completion date of September 5, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $19,447.53 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of TALTZ 80 MG/ML auto-injector (2-pack) pharmaceutical products. This firm fixed-price delivery order, which concludes on August 15, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters and a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,660.30 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $23,115.58 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack), a pharmaceutical product used in the treatment of autoimmune conditions. This competitively awarded, firm fixed-price delivery order was issued on September 4, 2025, with an ultimate completion date of September 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order carries...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Taltz 80 mg/ml autoinjector medication with a ceiling value of $17,030.96. This firm fixed-price delivery order, which is set to conclude on August 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a $4,083.21 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack) on July 28, 2025, with completion targeted for July 29, 2025. This non-competitive delivery order utilizes firm fixed-price pricing and is fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The award represents a single-line pharmaceutical procurement supporting federal medical supply needs, likely for military or veteran healthcare...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBHD1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $24,715.91 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical supplies on September 4, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and is a major pharmaceutical distributor specializing in federal medical procurement for military and veteran healthcare systems. This award represents a child delivery order issued under a larger contract vehicle. This delivery order derives from AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. The Defense Logistics Agency's Medical Supply Chain leverages this contract to procure specialized medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains for Defense Health Agency and other federal healthcare systems. The September 5, 2025 ultimate completion date reflects the time-sensitive nature of pharmaceutical delivery requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.7k | 9/4/25 |